arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 12/2014 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Varicella vaccination: What's new?

    NEW ON THE MARKET

    Lurasidone (LATUDA) for schizophrenia

    THERAPY FROM A CRITICAL VIEWPOINT

    On the duration of dual antiplatelet therapy after drug-eluting stents

    a-t READER'S QUESTIONS AND COMMENTS

    Update on mitoxantrone (RALENOVA) for multiple sclerosis

    IN BRIEF

    Marketing authorisations of 80 generic drugs suspended in Germany due to falsified bioequivalence trials from India

    Reports of deaths in Italy - FLUAD rehabilitated

    Adulterated dietary supplements - no end in sight

    European Commission - medical devices now, after all, belong to the industry directorate

    CURRENT ADR NETWORK REPORT

    Diverticulitis with denosumab (PROLIA)
    free

    SIDE EFFECTS

    Hangover: initial dose of zopiclone (e.g. XIMOVAN) halved in Canada

    e a-t IN INTERNET

    Advertising for the intranasal flu vaccine FLUENZ in kindergartens

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles